Teva has announced the launch of Pioglitazone HCl tablets, the generic version of Takeda‘s Actos.

Pioglitazone HCl tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and as monotherapy or in combination with metformin, insulin, or a sulfonylurea. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis.

Teva’s Pioglitazone HCl tablets are available in 15mg, 30mg, and 45mg dosage strengths in 30-, 90-, and 500-count bottles.

For more information call (215) 591-3000 or visit